SCHEMBL31644530

SCHEMBL31644530

COC(=O)c1c(Cl)nc(C)c(Cl)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
ALDH1A1 P00352 4/20 0.49
HPGD P15428 2/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 2/20 0.37
ACHE P22303 1/20 0.37
PLA2G2A P14555 1/20 0.37
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19023262 0.81 NPSR1 (0.41) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL9704498 0.79 ALDH1A1 (0.53) LMNAALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL31440847 0.79 ALDH1A1 (0.53) LMNAALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL31644323 0.78 ALDH1A1 (0.49) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL21906090 0.78 ALDH1A1 (0.56) LMNAALDH1A1SMN1; SMN2KDM4EPOLB
SCHEMBL21906012 0.77 POLB (0.52) LMNAALDH1A1SMN1; SMN2KMT2AMAPT
SCHEMBL62649 0.76 KMT2A (0.41) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL31368630 0.76 KMT2A (0.41) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL31368629 0.76 KMT2A (0.41) LMNAALDH1A1HPGDGAASMN1; SMN2
SCHEMBL29250205 0.75 SCN10A (0.35) LMNAALDH1A1HPGDGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025131049-A1 DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES AND USES THEREOF IGNIS THERAPEUTICS (SUZHOU) LIMITED (CN) 2025-06-26 WO disclosed